{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:51:55Z","timestamp":1752670315035,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"ZonMw research line Rational Pharmacotherapy","award":["848016001."],"award-info":[{"award-number":["848016001."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00198-023-06906-4","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T10:01:53Z","timestamp":1695290513000},"page":"69-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-0712","authenticated-orcid":false,"given":"Lieke","family":"Maas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-5087","authenticated-orcid":false,"given":"Nele","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5535-3119","authenticated-orcid":false,"given":"Marloes","family":"van Onna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-580X","authenticated-orcid":false,"given":"Dennis","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Bours","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-3781","authenticated-orcid":false,"given":"Trudy","family":"van der Weijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-2232","authenticated-orcid":false,"given":"Joop P.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-1592","authenticated-orcid":false,"given":"Marsha","family":"van Oostwaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7662-3990","authenticated-orcid":false,"given":"Caroline E.","family":"Wyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-9258","authenticated-orcid":false,"given":"Micka\u00ebl","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-9533","authenticated-orcid":false,"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"1","key":"6906_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82. https:\/\/doi.org\/10.1007\/s11657-020-00871-9","journal-title":"Arch Osteoporos"},{"issue":"1","key":"6906_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G, Norton N, Halbout P, Cooper C et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15(1):59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","journal-title":"Arch Osteoporos"},{"issue":"4","key":"6906_CR3","doi-asserted-by":"publisher","first-page":"e027049","DOI":"10.1136\/bmjopen-2018-027049","volume":"9","author":"F Fatoye","year":"2019","unstructured":"Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4):e027049. https:\/\/doi.org\/10.1136\/bmjopen-2018-027049","journal-title":"BMJ Open"},{"issue":"11","key":"6906_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00198-019-05104-5","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Cornelissen D, Vrijens B, Abrahamsen B, Al-Daghri N, Biver E et al (2019) Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporos Int 30(11):2155\u20132165. https:\/\/doi.org\/10.1007\/s00198-019-05104-5","journal-title":"Osteoporos Int"},{"issue":"6","key":"6906_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.amjmed.2011.01.013","volume":"124","author":"VM Montori","year":"2011","unstructured":"Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA et al (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med 124(6):549\u2013556. https:\/\/doi.org\/10.1016\/j.amjmed.2011.01.013","journal-title":"Am J Med"},{"key":"6906_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1745-6215-10-113","volume":"10","author":"LJ Pencille","year":"2009","unstructured":"Pencille LJ, Campbell ME, Van Houten HK, Shah ND, Mullan RJ, Swiglo BA et al (2009) Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials 10:113. https:\/\/doi.org\/10.1186\/1745-6215-10-113","journal-title":"Trials"},{"issue":"4","key":"6906_CR7","doi-asserted-by":"publisher","first-page":"e18468","DOI":"10.1371\/journal.pone.0018468","volume":"6","author":"EA Scoville","year":"2011","unstructured":"Scoville EA, de Leon Ponce, Lovaton P, Shah ND, Pencille LJ, Montori VM (2011) Why do women reject bisphosphonates for osteoporosis?. A videographic study. PLoS One 6(4):e18468. https:\/\/doi.org\/10.1371\/journal.pone.0018468","journal-title":"PLoS One"},{"issue":"9","key":"6906_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00198-020-05378-0","volume":"31","author":"D Cornelissen","year":"2020","unstructured":"Cornelissen D, de Kunder S, Si L, Reginster JY, Evers S, Boonen A et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645\u20131669. https:\/\/doi.org\/10.1007\/s00198-020-05378-0","journal-title":"Osteoporos Int"},{"issue":"11","key":"6906_CR9","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/jbmr.4701","volume":"37","author":"KAP Ralston","year":"2022","unstructured":"Ralston KAP, Hauser B, Paskins Z, Ralston SH (2022) Effective communication and the osteoporosis care gap. J Bone Mineral Res 37(11):2049\u201354. https:\/\/doi.org\/10.1002\/jbmr.4701","journal-title":"J Bone Mineral Res"},{"issue":"6","key":"6906_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4103\/ijem.IJEM_606_18","volume":"22","author":"M Chadha","year":"2018","unstructured":"Chadha M, Shingare A, Prasanth A, Chauhan P, Shah NF (2018) Fracture liaison service: prevention by coordination. Indian J Endocrinol Metab 22(6):719\u2013721. https:\/\/doi.org\/10.4103\/ijem.IJEM_606_18","journal-title":"Indian J Endocrinol Metab"},{"issue":"10","key":"6906_CR11","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00198-020-05442-9","volume":"31","author":"P van den Berg","year":"2020","unstructured":"van den Berg P, van Haard PMM, Geusens PP, van den Bergh JP, Schweitzer DH (2020) Characterization of fracture liaison service non-responders after invitation by home visits and questionnaires. Osteoporos Int 31(10):2007\u20132015. https:\/\/doi.org\/10.1007\/s00198-020-05442-9","journal-title":"Osteoporos Int"},{"issue":"6","key":"6906_CR12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jval.2017.02.006","volume":"20","author":"T Dunnewind","year":"2017","unstructured":"Dunnewind T (2017) Economic consequences and potential preventable costs related to osteoporosis in the Netherlands. Value Health 20(6):762\u20138. https:\/\/doi.org\/10.1016\/j.jval.2017.02.006","journal-title":"Value Health"},{"key":"6906_CR13","first-page":"184","volume":"2","author":"A Ratliff","year":"1999","unstructured":"Ratliff A (1999) What is a good decision. Eff Clin Pract 2:184\u2013197","journal-title":"Eff Clin Pract"},{"doi-asserted-by":"publisher","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (4). https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5","key":"6906_CR14","DOI":"10.1002\/14651858.CD001431.pub5"},{"issue":"8","key":"6906_CR15","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s00198-016-3555-1","volume":"27","author":"M Hiligsmann","year":"2016","unstructured":"Hiligsmann M, Ronda G, van der Weijden T, Boonen A (2016) The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis. Osteoporos Int 27(8):2489\u20132496. https:\/\/doi.org\/10.1007\/s00198-016-3555-1","journal-title":"Osteoporos Int"},{"issue":"1","key":"6906_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1186\/s12891-021-04743-2","volume":"22","author":"D Cornelissen","year":"2021","unstructured":"Cornelissen D, Boonen A, Evers S, van den Bergh JP, Bours S, Wyers CE et al (2021) Improvement of osteoporosis Care Organized by Nurses: ICON study - protocol of a quasi-experimental study to assess the (cost)-effectiveness of combining a decision aid with motivational interviewing for improving medication persistence in patients with a recent fracture being treated at the fracture liaison service. BMC Musculoskelet Disord 22(1):913. https:\/\/doi.org\/10.1186\/s12891-021-04743-2","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"6906_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/0272989x211035681","volume":"41","author":"D Stacey","year":"2021","unstructured":"Stacey D, Volk RJ (2021) The International Patient Decision Aid Standards (IPDAS) collaboration: evidence update 2.0. Med Decis Making 41(7):729\u201333. https:\/\/doi.org\/10.1177\/0272989x211035681","journal-title":"Med Decis Making"},{"issue":"7","key":"6906_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/0272989x211014163","volume":"41","author":"HO Witteman","year":"2021","unstructured":"Witteman HO, Maki KG, Vaisson G, Finderup J, Lewis KB, Dahl Steffensen K et al (2021) Systematic development of patient decision aids: an update from the IPDAS collaboration. Med Decis Making 41(7):736\u2013754. https:\/\/doi.org\/10.1177\/0272989x211014163","journal-title":"Med Decis Making"},{"doi-asserted-by":"publisher","unstructured":"Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T (2013) A systematic development process for patient decision aids. BMC Med Inform Decis Mak 13 Suppl 2(Suppl 2):S2. https:\/\/doi.org\/10.1186\/1472-6947-13-s2-s2","key":"6906_CR19","DOI":"10.1186\/1472-6947-13-s2-s2"},{"issue":"2","key":"6906_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/hex.12843","volume":"22","author":"T van der Weijden","year":"2019","unstructured":"van der Weijden T, Dreesens D, Faber MJ, Bos N, Drenthen T, Maas I et al (2019) Developing quality criteria for patient-directed knowledge tools related to clinical practice guidelines. A development and consensus study. Health Expect 22(2):201\u20138. https:\/\/doi.org\/10.1111\/hex.12843","journal-title":"Health Expect"},{"unstructured":"(2022) Osteoporose en fractuurpreventie: Federatie Medisch Specialisten. https:\/\/richtlijnendatabase.nl\/richtlijn\/osteoporose_en_fractuurpreventie\/startpagina_-_osteoporose_en_fractuurpreventie.html. Accessed 21 December 2022","key":"6906_CR21"},{"doi-asserted-by":"publisher","unstructured":"Te Kampe R, Boonen A, Jansen T, Janssen M, de Vries H, van Durme C (2022) Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients. RMD Open 8(1). https:\/\/doi.org\/10.1136\/rmdopen-2021-001979","key":"6906_CR22","DOI":"10.1136\/rmdopen-2021-001979"},{"issue":"4","key":"6906_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3978\/j.issn.2223-4292.2015.08.01","volume":"5","author":"JF Griffith","year":"2015","unstructured":"Griffith JF (2015) Identifying osteoporotic vertebral fracture. Quant Imaging Med Surg 5(4):592\u2013602. https:\/\/doi.org\/10.3978\/j.issn.2223-4292.2015.08.01","journal-title":"Quant Imaging Med Surg"},{"issue":"8","key":"6906_CR24","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","volume":"32","author":"N Li","year":"2021","unstructured":"Li N, Hiligsmann M, Boonen A, van Oostwaard MM, de Bot RTAL, Wyers CE et al (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32(8):1517\u20131530. https:\/\/doi.org\/10.1007\/s00198-021-05911-9","journal-title":"Osteoporos Int"},{"unstructured":"(2022) Farmacotherapeutisch kompas: Zorginstituut Nederland. https:\/\/www.farmacotherapeutischkompas.nl\/. Accessed 5 Dec 2022","key":"6906_CR25"},{"issue":"4","key":"6906_CR26","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2106\/jbjs.L.00223","volume":"96","author":"KM Huntjens","year":"2014","unstructured":"Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B et al (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96(4):e29. https:\/\/doi.org\/10.2106\/jbjs.L.00223","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"6906_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11914-010-0023-2","volume":"8","author":"TA van Geel","year":"2010","unstructured":"van Geel TA, Huntjens KM, van den Bergh JP, Dinant GJ, Geusens PP (2010) Timing of subsequent fractures after an initial fracture. Curr Osteoporos Rep 8(3):118\u2013122. https:\/\/doi.org\/10.1007\/s11914-010-0023-2","journal-title":"Curr Osteoporos Rep"},{"issue":"10","key":"6906_CR28","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00198-020-05479-w","volume":"31","author":"Z Paskins","year":"2020","unstructured":"Paskins Z, Torres Roldan VD, Hawarden AW, Bullock L, Meritxell Urtecho S, Torres GF et al (2020) Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporos Int 31(10):1837\u20131851. https:\/\/doi.org\/10.1007\/s00198-020-05479-w","journal-title":"Osteoporos Int"},{"issue":"1","key":"6906_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15605\/jafes.035.01.15","volume":"35","author":"M Carrissa Abigail Roxas","year":"2020","unstructured":"Carrissa Abigail Roxas M, Jimeno C, Palileo-Villanueva L, Macalalad-Josue AA, Sandoval MA, Fernandez JA (2020) Development of a patient decision aid for the treatment of osteoporosis among Filipino postmenopausal women. J ASEAN Fed Endocr Soc 35(1):93\u2013101. https:\/\/doi.org\/10.15605\/jafes.035.01.15","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"1","key":"6906_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0272989x09342279","volume":"30","author":"KJ McCaffery","year":"2010","unstructured":"McCaffery KJ, Smith SK, Wolf M (2010) The challenge of shared decision making among patients with lower literacy: a framework for research and development. Med Decis Making 30(1):35\u201344. https:\/\/doi.org\/10.1177\/0272989x09342279","journal-title":"Med Decis Making"},{"issue":"3","key":"6906_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1369-7625.2006.00393.x","volume":"9","author":"KA Silvia","year":"2006","unstructured":"Silvia KA, Sepucha KR (2006) Decision aids in routine practice: lessons from the breast cancer initiative. Health Expect 9(3):255\u2013264. https:\/\/doi.org\/10.1111\/j.1369-7625.2006.00393.x","journal-title":"Health Expect"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06906-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T08:04:40Z","timestamp":1705046680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6906"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06906-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The department of Marloes van Onna has received consultancy fees from Novartis, Pfizer, and Galapagos and a research grant from Pfizer. The department of Annelies Boonen has received consultancy fees from AbbVie, Novartis, and Galapagos. Micka\u00ebl Hiligsmann has received research grants paid to his institution by Amgen, Radius Health, and ViiV Healthcare, and consultancy fees from UCB. The department of Joop P. van den Bergh has received consultancy fees from UCB and Amgen. Dennis Cornelissen, Nele Raskin, Marsha van Oostwaard, Caroline E. Wyers, Trudy van der Weijden, Sandrine Bours, and Lieke Maas declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}